about
Over-, under- and misuse of pain treatment in GermanyEfficacy and effectiveness of recombinant human activated protein C in severe sepsis of adultsMusic therapy in palliative setting.Health Technology Assessment - science or art?Why not integrate ethics in HTA: identification and assessment of the reasons.Concepts of care for people with dementia.Therapy of the burnout syndromeTherapy of unspecific tinnitus without organic causeMedical specialist attendance in nursing homes.Interferons and natalizumab for multiple sclerosis.Minimally invasive surgical procedures for the treatment of lumbar disc herniationValidity and cost-effectiveness of methods for screening of primary open angle glaucoma.Ventricular assist devices for heart failure.Endodontic treatment of molars.Bypass materials in vascular surgery.Mistletoe treatments for minimising side effects of anticancer chemotherapy.Medical and health economic assessment of radiosurgery for the treatment of brain metastasis.Health Technology Assessment of laparoscopic compared to conventional surgery with and without mesh for incisional hernia repair regarding safety, efficacy and cost-effectiveness.New-onset diabetes and antihypertensive treatmentComparison of tools for assessing the methodological quality of primary and secondary studies in health technology assessment reports in Germany.Invasive home mechanical ventilation, mainly focused on neuromuscular disorders.Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.Effectiveness of pharmaceutical therapy of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults - health technology assessment.The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcersDifferential diagnostic of the burnout syndrome.Assessments tools for risk prediction of cardiovascular diseases.Arthroplasty register for Germany.Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac eventsEvaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart diseaseOverweight prevention in adolescents and children (behavioural and environmental prevention)Methods for assessment of innovative medical technologies during early stages of development.Effectiveness and efficiency of CT-colonography compared to conventional colonoscopy for the early detection and diagnosis of colorectal cancerHuman papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursorsBehaviour therapy for obesity treatment considering approved drug therapy.Longevity of dental amalgam in comparison to composite materialsThe treatment of Parkinson's disease with dopamine agonists.Evaluation of medical and health economic effectiveness of bariatric surgery (obesity surgery) versus conservative strategies in adult patients with morbid obesity.Intravascular brachytherapy for peripheral vascular disease.Measurement of fractional flow reserve to guide decisions for percutaneous coronary interventionUsing decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system.
P1433
Q24609818-3713D10B-A482-4514-B6A5-E2BC77CCF5CEQ28743919-476EFFE9-BB2D-4B77-A107-173A39988E03Q30352508-2CAC3A85-ED9F-465D-88BE-BE0A204C2411Q30352759-7C5114CC-9786-4A0C-BDEE-E9CDAF5D27B1Q30369550-21674657-034E-443C-A46C-EAAE313B5BC4Q30399293-94FAC91B-2B46-4354-B8EB-05CFD4749BBEQ30421329-242669ED-2F2E-4487-8252-5FDE17A077B7Q30477175-14B5E5D2-7F4B-4B75-9148-00A1CE89A8E9Q30540477-8631F2E2-E5AB-40BD-B6CC-460758FB5BF4Q30997435-4E06C117-94FC-4085-AA7B-98D2848C181CQ30997454-4C3B623B-F533-421A-B6CD-C29B4B1A0F5AQ30997470-7906C5BA-CBE9-4DA2-83C6-52126538E803Q30997488-4F0EE594-8996-4ADA-8431-8901F6083A6DQ30997505-FF74C95F-644F-43D7-9A7E-2FB4F5B703D1Q30997519-D65BCCEF-CA33-44CF-93DE-69C486B93BF9Q30997550-3B5E7D36-FB37-4E11-8318-7BA9CB3DA366Q33810948-983FD410-65D8-466E-B2C1-8217BA56C325Q33810954-A308341C-6E1F-4DED-B2D0-23A47D46624EQ34443818-96D5604E-1B49-434A-9E8E-EB5E4F9F972EQ34443827-3094D9EC-F3C3-480B-9614-65DF2CAE20C7Q34443830-4DE14E19-F846-4259-9836-8649AEF9BF9FQ34443836-FC9E38D0-DDD1-4688-BF95-B6D40D7C037EQ34443844-7B9CAAFB-8632-4078-9A9B-43B52152B46CQ34443849-8A17EBE6-7215-4303-8110-5453A209A596Q34443855-348489BB-54AD-4B37-8730-A7237ED4557FQ34445337-A5384E77-BF85-4D8C-94BC-0EF5AA876F24Q34445344-03ADD5BC-4CED-4FD3-8CD6-055D2C66AFC8Q34445351-D80FB0EE-08D5-4AD4-A5E7-0BE5885E3AF3Q34445356-1405DFDC-ABD3-4368-B68E-96139D28C8EAQ34445363-1B4F4A30-A293-4CD6-B1E6-D71A926DB0BFQ34445369-54148D5E-26AD-465B-8629-CAA9CBAE23AAQ34445376-19C5089E-3D2F-4539-B2A0-AF62ABB5F184Q34445383-1D536AC9-F77B-4341-9126-B627C35278B8Q34445409-082030DA-3F19-4E14-8B81-78D602C6CF36Q34445422-B1C6C3CA-E6C9-43D9-B89B-B566FBBCDF0AQ34445427-58349670-8A8E-46E2-B325-90F4C79CBAA1Q34445440-514C23D0-E54C-4513-8985-63FD95C34656Q34445445-9BFDA9C9-2135-4231-9563-7C060F4811FFQ34445454-87103B4D-D851-445B-BDBD-44E6559AA269Q34445478-F09479DD-7D62-4632-AA62-70F68687E6F9
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van German Medical Science GMS Publishing House
@nl
name
GMS health technology assessment
@ast
GMS health technology assessment
@en
GMS health technology assessment
@es
GMS health technology assessment
@nl
type
label
GMS health technology assessment
@ast
GMS health technology assessment
@en
GMS health technology assessment
@es
GMS health technology assessment
@nl
altLabel
GMS Health Technol Assess
@en
GMS Health Technology Assessment
@en
prefLabel
GMS health technology assessment
@ast
GMS health technology assessment
@en
GMS health technology assessment
@es
GMS health technology assessment
@nl
P31
P1055
P1277
P1476
GMS health technology assessment
@en